Tag: Ranibizumab

Preventive effect of intravitreal injection of ranibizumab on rehaemorrhagia following vitrectomy for prolifarative diabetic retinopathy

2017, No. 01, Clinical Science

Authors: Ma Lie,  Li Xiaoxin DOI: 10.3760/cma.j.issn.2095-0160.2017.01.014 Published 2017-01-10 Cite as Chin J Exp Ophthalmol, 2017,35(1): 69-72. Abstract                              [Download PDF] [Read Full Text] Background Vitrectomy is a primary approach to the treatment of proliferative diabetic retinopathy (PDR). However, postoperative rehaemorrhagia often occur.Ranibizumab is […]

Therapeutic efficacy and significance of intravitreal injection of ranibizumab for age-related macular degeneration with subfoveal scarring and active lesion

2017, No. 01, Clinical Science

Authors: Li Juanjuan,  Li Hua DOI: 10.3760/cma.j.issn.2095-0160.2017.01.009 Published 2017-01-10 Cite as Chin J Exp Ophthalmol, 2017,35(1): 42-46. Abstract                              [Download PDF] [Read Full Text] Background Intravitreal injection of ranibizumab is a primary approach to the treatment of wet age-related macular degeneration (wAMD), but whether it is necessary for […]

Efficacy and safety of post-sclera injecting triamcinolone acetonide for diabetic macular edema

2017, No. 07, Clinical Science

Authors: Liu Ningshu,  Li Shiying,  Sun Cheng,  Li Sha,  Xu Biwei,  Qin Wei  DOI: 10.3760/cma.j.issn.2095-0160.2017.07.010 Published 2017-07-10 Cite as Chin J Exp Ophthalmol, 2017,35(07): 622-627. Abstract                              [Download PDF] [Read Full Text] Background Diabetic macular edema (DME) is one of serious ocular complications of diabetes mellitus and is often treated by laser […]

Clinical effect of vitreoretinal surgery combined with intravitreal injection of conbercept or ranibizumab on severe proliferative diabetic retinopathy

2017, No. 10, Clinical Science

Authors: Guo Jing,  Chen Song,  Wang Yun,  Liang Xu DOI: 10.3760/cma.j.issn.2095-0160.2017.10.013 Published 2017-10-10 Cite as Chin J Exp Ophthalmol, 2017,35(10): 914-919. Abstract                              [Download PDF] [Read Full Text] Background Vitreoretinal surgery (VRS) is the main treatment of severe proliferative diabetic retinopathy (PDR), intravitreal injection of anti-VEGF drugs before VRS on […]

Influence of repetitive intravitreal ranibizumab for neovascular age-related macular degeneration on retinal pigment epithelium and choroidal thickness

2017, No. 10, Clinical Science

Authors: Qi Hang,  Chen Changzheng,  Su Yu,  Yi Zuohuizi DOI: 10.3760/cma.j.issn.2095-0160.2017.10.012 Published 2017-10-10 Cite as Chin J Exp Ophthalmol, 2017,35(10): 909-913. Abstract                               [Download PDF] [Read Full Text] Background Intravitreal injection of ranibizumab (IVR) is one of the most effective therapies for neovascular age-related macular degeneration (nAMD). Understanding the influence […]

Long-term efficacy of intravitreal ranibizumab therapy for idiopathic choroidal neovascularization

2018, No. 09, Clinical Science

Authors: Zhang Ming,  Di Rong,  Kang Qianyan,  Fan Xiaojuan DOI: 10.3760/cma.j.issn.2095-0160.2018.09.009 Published 2018-09-10 Cite as Chin J Exp Ophthalmol, 2018,36(9): 699-703. Abstract                              [Download PDF] [Read Full Text] Objective To observe the long-term clinical efficacy of intravitreal ranibizumab (IVR) in patients with idiopathic choroidal neovascularization (ICNV), and to explore the […]

Problems and challenges of anti-vascular endothelial growth factor therapy for ocular neovescularization diseases

2019, No. 01, Editorial

Authors: Chen Youxin,  Tang Jia DOI: 10.3760/cma.j.issn.2095-0160.2019.01.001 Published 2019-01-10 Cite as Chin J Exp Ophthalmol, 2019,37(1): 1-4. Abstract                              [Download PDF] [Read Full Text] Anti-vascular endothelial growth factor (VEGF) therapy is a major strategy for treating ocular neovascular diseases nowadays.It has revolutionarily improved the […]